A paper published in September warns adding autism to the list of vaccine injuries for which patients can receive federal compensation would be astronomically expensive and grind the program to halt, but a vaccine litigation expert alleges that’s an inflated estimate based on faulty assumptions.
The American Medical Association’s new Center for Digital Health and Artificial Intelligence will work with regulators, policymakers and technology leaders to “shape benchmarks for safe and effective use of AI in medicine and digital health tools,” the major doctors’ group announced Monday (Oct. 20).
A survey by YouGov finds “a deep trust gap between Americans and AI-powered mental health tools -- even as awareness grows,” with few respondents reporting having actually used such a service while a majority lack confidence that the tools could handle “human nuance.
Months after unveiling the findings of a years-long investigation of the growth of the 340B drug discount program and the impact certain operational issues and covered entity practices have had on patients, the Senate health committee is due to revisit ongoing concerns with the program next week.
Robert Malone, who sits on the CDC vaccine advisory committee reconfigured by HHS Secretary Robert F. Kennedy Jr., said HHS’ new leaders are “reshaping the foundation of U.S. vaccine policy” and taking on the “cult of vaccination.”
The number of employees at FDA’s drugs and biologics centers have significantly decreased in 2025, with few new hires being made despite the centers’ mandates to maintain adequate staffing to meet user fee goals, according to data posted by FDA Thursday (Oct. 16).
One bipartisan think tank suggests Congress implement income caps for enhanced ACA subsidies set to expire at the end of the year, as the policy is currently being floated amongst lawmakers searching for a solution to extend the tax credits and end the government shutdown.
CMS Administrator Mehmet Oz said over 400 stakeholders, including companies building artificial intelligence tools, have signed onto the CMS Interoperability Framework since his agency announced the voluntary pledge with just over 60 initial signatories in late July.
Sen. Bill Cassidy (R-LA) in a Thursday (Oct. 16) letter is encouraging FDA to study safety concerns resulting from the removal of in-person dispensing requirements of mifepristone, that, if reinstated, would eliminate telehealth access to abortion pills.
As House Republicans press the administration to move forward on a delayed No Surprises Act provision that will allow consumers to get cost estimates from a provider or insurer in advance of a service, a key health IT industry group warns quickly implementing the provision that was supposed to go into effect in 2022 could backfire.
